Bloomberg Law
Health Law & Business
LinkedIn

Pfizer Gets US FDA Approval for Etrasimod in Ulcerative Colitis

Oct. 13, 2023, 1:02 PM UTC
Ilya Banares
Ilya Banares
Bloomberg News

Pfizer said the US FDA has approved etrasimod for adults with moderately to severely active ulcerative colitis, with a recommended dose of 2 mg.

To view the source of this information, click here

To contact the reporter on this story:
Ilya Banares in Toronto at ibanares@bloomberg.net

To contact the editor responsible for this story:
Sunil Kesur at skesur@bloomberg.net

© 2023 Bloomberg L.P. All rights reserved. Used with permission.

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.